WebApr 10, 2024 · Research Reports for GSK Analyst Snapshot ( = Change in last 30 days) View All Zacks Rank #1 Strong Buys More Premium Research » Premium Research: Industry Analysis See all Medical -... WebApr 25, 2024 · GlaxoSmithKline plc GSK will report first-quarter 2024 results on Apr 27, before market open. In the last reported quarter, the company delivered an earnings …
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By
WebFeb 10, 2024 · Glaxo reports financial figures under three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. Respiratory Business Remains Strong Pharmaceuticals sales were up 25% at CER driven by... Web21 hours ago · The total indicative share trading liquidity for Glaxosmithkline Consumer Nigeria Plc (GLAXOS.ng) in the past 12 months, as of 3rd April 2024, is US$1.52M (NGN645.53M). An average of US$126.46K (NGN53.79M) per month. Glaxosmithkline Consumer Nigeria Plc 2024 annual report Company Profile arti matur sembah nuwun
Glexo, the Global Exopolitics Organization
WebJul 15, 2024 · On June 23, 2024, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a … WebFeb 4, 2024 · GlaxoSmithKline plc GSK will report fourth-quarter and full year 2024 results on Feb 9, before market open. In the last reported quarter, the company delivered an … WebMar 16, 2024 · GlaxoSmithKline Pharmaceuticals Ltd. has an average target of 1374.00. The consensus estimate represents an upside of 6.64% from the last price of 1288.45. Reco - This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold) Target - Broker has maintained previous recommendation but reduced share price target. arti material dalam audit